GlassScriptPhysician profile
Tracy J Slager
NPI 1538395397
$5,479.88
in general payments reported to CMS, 2019-2025
43 companies · $692 in 2025
The $692 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $475 · 2021: $1,040 · 2022: $926 · 2023: $649 · 2024: $786 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,319.02 | 2019-2025 | Vraylar, Ubrelvy |
| Novo Nordisk INC | $717.05 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $371.07 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $347.60 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $310.60 | 2019-2024 | Evenity, Prolia, Repatha |
| Pfizer INC. | $278.62 | 2019-2025 | |
| Astellas Pharma US INC | $242.52 | 2019-2024 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $234.22 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Allergan, INC. | $158.85 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $158.30 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $148.83 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $130.61 | 2022-2024 | |
| Intuitive Surgical, INC. | $105.20 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $96.49 | 2019-2022 | |
| Eisai INC. | $72.12 | 2020-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Slager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.